Stay updated on IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Sign up to get notified when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    A new revision label v3.5.3 was added to the history, and the older v3.5.2 was removed. This reflects an administrative update to the page's revision history rather than substantive content changes.
    Difference
    0.1%
    Check dated 2026-04-30T03:18:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The Record History page reflects a new version submission date and an updated “Revision” identifier, along with the latest “Study Status” update entry in the version list.
    Difference
    0.5%
    Check dated 2026-04-22T18:00:09.000Z thumbnail image
  4. Check
    46 days ago
    Change Detected
    Summary
    The study's revision history now includes a new entry for v3.5.0 and removes the v3.4.3 entry. This updates the version history display without changing the underlying study data.
    Difference
    0.1%
    Check dated 2026-03-25T00:35:37.000Z thumbnail image
  5. Check
    61 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.3) was added and the previous revision (v3.4.2) removed on the page.
    Difference
    0.1%
    Check dated 2026-03-10T14:12:48.000Z thumbnail image
  6. Check
    82 days ago
    Change Detected
    Summary
    The change is a minor site-wide version update from Revision: v3.4.1 to v3.4.2, affecting only the page footer and not study data or navigation. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-17T03:15:10.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    A new history entry Revision: v3.4.1 was added and an older government funding notice was removed; these are administrative updates that do not change trial information.
    Difference
    0.7%
    Check dated 2026-02-09T22:43:30.000Z thumbnail image

Stay in the know with updates to IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IRX-2, Cyclophosphamide, Nivolumab in Liver Cancer Clinical Trial page.